Literature DB >> 11805446

Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro.

M Hijikata1, S Mishiro, C Miyamoto, Y Furuichi, M Hashimoto, Y Ohta.   

Abstract

We have previously reported a single nucleotide polymorphism (SNP) at nucleotide (nt) position -88 (G or T) within an interferon-stimulated response element-like sequence in the promoter region of the MxA gene, which correlated with responsiveness of hepatitis C patients to interferon. Upstream of it, we then identified another SNP (C or A at nt -123) and investigated whether this SNP also correlates with interferon responsiveness. The two SNPs showed a high linkage to each other: all the individuals having G at -88 had C at -123, and 73% of those having T at -88 had A at -123. As was expected from this observation, the SNP at -123 also exhibited a correlation with interferon responsiveness (C/C homozygotes were more frequent among nonresponders than among responders: 65% of 107 vs. 40% of 52, p = 0.0028). These in vivo data from patients were further supported by results from in vitro experiments. The MxA promoter sequence with A at -123 and T at -88 showed about 4-fold higher activity of upregulating the downstream reporter gene than that with C at -123 and G at -88, in a luciferase reporter assay. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11805446     DOI: 10.1159/000050075

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  17 in total

1.  Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel.

Authors:  David L Barker; Mark S T Hansen; A Fawad Faruqi; Diane Giannola; Orlando R Irsula; Roger S Lasken; Martin Latterich; Vladimir Makarov; Arnold Oliphant; Jonathon H Pinter; Richard Shen; Irina Sleptsova; William Ziehler; Eric Lai
Journal:  Genome Res       Date:  2004-05       Impact factor: 9.043

2.  Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.

Authors:  Xiaowen Su; Leland J Yee; KyungAh Im; Shannon L Rhodes; YongMing Tang; Xiaomei Tong; Charles Howell; Darmendra Ramcharran; Hugo R Rosen; Milton W Taylor; T Jake Liang; Huiying Yang
Journal:  J Hepatol       Date:  2008-05-20       Impact factor: 25.083

3.  The myxovirus resistance A (MxA) gene -88G>T single nucleotide polymorphism is associated with prostate cancer.

Authors:  Shanora Glymph; Sanjay Mandal; Ashley Evans Knowell; Fisseha Abebe; Jaideep Chaudhary
Journal:  Infect Genet Evol       Date:  2013-02-22       Impact factor: 3.342

4.  Myxovirus resistance protein A (MxA) polymorphism is associated with IFNβ response in Iranian multiple sclerosis patients.

Authors:  Arezou Sayad; Soudeh Ghafouri-Fard; Mir Davood Omrani; Rezvan Noroozi; Mohammad Taheri
Journal:  Neurol Sci       Date:  2017-04-06       Impact factor: 3.307

5.  Influence of MX1 promoter rs2071430 G/T polymorphism on susceptibility to systemic lupus erythematosus.

Authors:  Suad AlFadhli; Mashael Al-Mutairi; Bader Al Tameemi; Rasheeba Nizam
Journal:  Clin Rheumatol       Date:  2016-01-27       Impact factor: 2.980

6.  Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics.

Authors:  John E Tavis; Maureen J Donlin; Rajeev Aurora; Xiaofeng Fan; Adrian M Di Bisceglie
Journal:  Genome Med       Date:  2011-02-08       Impact factor: 11.117

Review 7.  Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses.

Authors:  Jennifer Juno; Keith R Fowke; Yoav Keynan
Journal:  Clin Dev Immunol       Date:  2011-11-03

8.  Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.

Authors:  Jing He; Dan Feng; Sake J de Vlas; Hongwei Wang; Arnaud Fontanet; Panhe Zhang; Sabine Plancoulaine; Fang Tang; Lin Zhan; Hong Yang; Tianbao Wang; Jan H Richardus; J Dik F Habbema; Wuchun Cao
Journal:  BMC Infect Dis       Date:  2006-07-06       Impact factor: 3.090

9.  Host genetic variations are associated with virological response to interferon therapy of chronic HCV in Han Chinese patients.

Authors:  Hongbo Chen; Yuanyuan Zhang; Peng Huang; Yin Xu; Jie Wang; Jing Su; Rongbin Yu
Journal:  J Biomed Res       Date:  2014-11

10.  Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B.

Authors:  Ana Luiza Dias Angelo; Lourianne Nascimento Cavalcante; Kiyoko Abe-Sandes; Taísa Bonfim Machado; Denise Carneiro Lemaire; Fernanda Malta; João Renato Pinho; Luiz Guilherme Costa Lyra; Andre Castro Lyra
Journal:  Clinics (Sao Paulo)       Date:  2013-10       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.